Charles River Laboratories International, Inc. (CRL)
185.47
+3.91
(+2.15%)
USD |
NYSE |
Jun 23, 11:53
Charles River Laboratories International Cash from Financing (Quarterly) : 347.72M for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 347.72M |
| December 31, 2025 | -51.86M |
| September 30, 2025 | -152.62M |
| June 30, 2025 | -246.06M |
| March 31, 2025 | -86.18M |
| December 31, 2024 | -75.88M |
| September 30, 2024 | -207.54M |
| June 30, 2024 | -285.86M |
| March 31, 2024 | 18.35M |
| December 31, 2023 | 123.57M |
| September 30, 2023 | -162.87M |
| June 30, 2023 | -71.46M |
| March 31, 2023 | 25.24M |
| December 31, 2022 | -248.96M |
| September 30, 2022 | -51.59M |
| June 30, 2022 | 271.44M |
| March 31, 2022 | -13.28M |
| December 31, 2021 | -218.97M |
| September 30, 2021 | 178.90M |
| June 30, 2021 | 517.96M |
| March 31, 2021 | 194.72M |
| December 31, 2020 | -59.23M |
| September 30, 2020 | -268.64M |
| June 30, 2020 | -104.10M |
| March 31, 2020 | 479.21M |
| Date | Value |
|---|---|
| December 31, 2019 | -39.04M |
| September 30, 2019 | -133.44M |
| June 30, 2019 | 473.51M |
| March 31, 2019 | -69.08M |
| December 31, 2018 | 0.563M |
| September 30, 2018 | -147.08M |
| June 30, 2018 | 719.51M |
| March 31, 2018 | -14.94M |
| December 31, 2017 | -53.01M |
| September 30, 2017 | -0.402M |
| June 30, 2017 | -80.74M |
| March 31, 2017 | -74.32M |
| December 31, 2016 | -23.46M |
| September 30, 2016 | -105.19M |
| June 30, 2016 | 512.30M |
| March 31, 2016 | 7.081M |
| December 31, 2015 | 15.99M |
| September 30, 2015 | 52.29M |
| June 30, 2015 | -65.66M |
| March 31, 2015 | 1.934M |
| December 31, 2014 | 17.12M |
| September 30, 2014 | -33.92M |
| June 30, 2014 | 84.36M |
| March 31, 2014 | -6.144M |
| December 31, 2013 | -15.91M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | -433.00M |
| Fortrea Holdings, Inc. | 0.00 |
| Medpace Holdings, Inc. | 12.67M |
| Inotiv, Inc. | 5.886M |
| Avantor, Inc. | -107.20M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 41.08M |
| Cash from Investing (Quarterly) | -407.84M |
| Free Cash Flow | 391.29M |
| Free Cash Flow Per Share (Quarterly) | -0.303 |
| Free Cash Flow to Equity (Quarterly) | -447.90M |
| Free Cash Flow to Firm (Quarterly) | -1.611M |
| Free Cash Flow Yield | 4.29% |